Trials / Completed
CompletedNCT01012388
Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color
Post-Marketing Study of Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Merz North America, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Post marketing study to assess the likelihood of hypertropic scarring, keloid formation and hyper- or hypopigmentation in patients with Fitzpatrick Skin Types IV, V, and VI receiving nasolabial fold treatment with Radiesse® Injectable Dermal Filler
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radiesse® Injectable Dermal Filler | Calcium hydroxylapatite particles suspected in an aqueous based gel carrier |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2007-12-01
- Completion
- 2008-02-01
- First posted
- 2009-11-13
- Last updated
- 2013-04-26
- Results posted
- 2009-12-23
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01012388. Inclusion in this directory is not an endorsement.